NASDAQ: FDMT - 4D Molecular Therapeutics, Inc.

Altı ay boyunca karlılık: -67.11%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı 4D Molecular Therapeutics, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında 4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc., компания, занимающаяся генной терапией на клинической стадии, разрабатывает продукты-кандидаты, используя свои векторы аденоассоциированных вирусов. Он разрабатывает портфель кандидатов на продукты генной терапии, специализируясь в трех терапевтических областях: офтальмология, кардиология и пульмонология.

daha fazla ayrıntı
У компании есть три продукта-кандидата, которые проходят клинические испытания: 4D-125, который проходит фазу 1/2 клинических испытаний для лечения пигментного ретинита, сцепленного с Х-хромосомой; 4D-110, который проходит фазу 1 клинических испытаний для лечения хориидеремии; и 4D-310, который проходит фазу 1/2 клинических испытаний для лечения болезни Фабри. Два его кандидата IND - это 4D-150 для лечения возрастной дегенерации желтого пятна и 4D-710 для лечения муковисцидоза легких. 4D Molecular Therapeutics, Inc. проводит исследования и сотрудничает с uniQure; Benitec; CRF; Рош; CFF; и AstraZeneca. Компания была основана в 2013 году, ее штаб-квартира находится в Эмеривилле, Калифорния.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2020-12-11
ISIN US35104E1001
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.4dmoleculartherapeutics.com
Цена ао 3.61
Günlük fiyat değişimi: -2.44% (3.695)
Haftalık fiyat değişimi: -4.88% (3.79)
Aylık fiyat değişimi: -20.24% (4.52)
3 ayda fiyat değişimi: -37.95% (5.81)
Altı ayda fiyat değişimi: -67.11% (10.96)
Yıllık fiyat değişimi: -89.95% (35.87)
3 yılda fiyat değişimi: -72.18% (12.96)
Yılbaşından bu yana fiyat değişimi: -35.05% (5.55)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 40.13 1
P/BV 0.5885 10
P/E 0 0
EV/EBITDA -0.9356 0
Toplam: 4.88

Yeterlik

İsim Anlam Seviye
ROA, % -35.74 0
ROE, % -39.31 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.131 10
Toplam: 9.4

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 196.04 10
karlılık Ebitda, % 239.98 10
karlılık EPS, % -66.19 0
Toplam: 8
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
VR Adviser, LLC 4 8.51
Blackrock Inc. 4 8.29
BVF Inc. 4 7.59
Janus Henderson Group PLC 3 6.18
Goldman Sachs Group Inc 3 5.91
Deep Track Capital, LP 3 5.87
Viking Global Investors, L.P. 3 5.68
Vanguard Group Inc 2 4.53
State Street Corporation 2 4.21
Polar Capital Holdings PLC 2 3.48

ETFPaylaşmak, %Yıllık karlılık, %Temettüler, %
Franklin Genomic Advancements Fund Franklin Genomic Advancements Fund 0.83177 1.54 0.22433
Virtus LifeSci Biotech Clinical Trials ETF 0.3858 63.04 0.33
iShares Micro-Cap ETF 0.15217 17.09 1.54048
Direxion Daily S&P Biotech Bull 3x Shares 0.13546 4067.92 0.25924
Invesco Nasdaq Biotechnology ETF 0.06714 28.58 0.8565
Future Tech ETF 0.05967 426.34 0.8416
Principal Healthcare Innovators ETF 0.05967 618.5 0.8416
ProShares Ultra Nasdaq Biotechnology 0.05777 51.7 0.85651
SPDR S&P Kensho New Economies Composite ETF 0.05681 21.57 0.88486
Vanguard U.S. Momentum Factor ETF 0.05 30.05 1.05834
Vanguard Russell 2000 Growth ETF 0.04 23.05 0.60264
Vanguard Russell 2000 ETF 0.03 17.16 1.48801
iShares Russell 2000 Growth ETF 0.02846 38.04 0.6026
Avantis U.S Small Cap Equity ETF 0.02841 27.77 1.68271
Schwab U.S. Small-Cap ETF 0.01706 17.47 1.51433
ProShares UltraPro Russell2000 0.01281 89.82 1.47873
Fidelity MSCI Health Care Index ETF 0.00724 3 1.46057
Humankind US Stock ETF 0.00569 18.81 1.99919
ProShares Hedge Replication ETF 0.00511 5.92 1.47892
Dimensional U.S. Core Equity 2 ETF 0.00336 30.76 1.47098
SPDR Portfolio MSCI Global Stock Market ETF 0.00201 17.99 2.19607
Dimensional US Core Equity Market ETF 0.00153 30.98 1.40618
Schwab U.S. Broad Market ETF 0.00112 24.86 1.43354
Avantis U.S. Equity ETF 0.00105 23.04 1.59151
iShares Russell 3000 ETF 0.001 24.83 1.43482
Dimensional U.S. Equity ETF 0.00055 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.08214.191.2



Süpervizör İş unvanı Ödeme Doğum yılı
Ms. Theresa Janke Co-Founder & Chief of Staff 652.32k 1975 (50 yıllar)
Dr. Scott P. Bizily J.D., Ph.D. Chief Legal Officer & Corporate Secretary N/A 1973 (52 yıl)
Dr. John F. Milligan Ph.D. Executive Chairman 150k 1961 (64 yıl)
Dr. David H. Kirn M.D. Co-Founder, CEO & Director 920.97k 1963 (62 yıl)
Dr. Robert Y. Kim M.B.A., M.D. Chief Medical Officer N/A 1961 (64 yıl)
Dr. Fariborz Kamal Ph.D. President & COO 678.4k 1963 (62 yıl)
Dr. An Song Ph.D. Chief Development Officer N/A
Mr. Uneek Mehra Chief Financial & Business Officer N/A 1972 (53 yıl)
Dr. Noriyuki Kasahara M.D., Ph.D. Chief Scientific Officer 13.6k 1963 (62 yıl)
Dr. Alan H. Cohen FAAAAI, FAAP, FACAAI, FCCP, M.D. Senior VP & Therapeutic Area Head of Pulmonology N/A 1961 (64 yıl)

Adres: United States, EmeryVille, CA , 5858 Horton Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.4dmoleculartherapeutics.com